Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Horvat

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Acta Chirurgica Iugoslavica|January 1, 1989
[Vascular procedures in oncology surgery]P Petrović, Z Horvat, M Fabri, et al.
The Annals of Pharmacotherapy|May 21, 2015
Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncologyMeagan S Barbee, Adebayo Ogunniyi, Troy Z Horvat, et al.
The Annals of Pharmacotherapy|June 5, 2015
Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic LeukemiaLarry W Buie, Joshua J Pecoraro, Troy Z Horvat, et al.
Medicinski Pregled|February 21, 1998
[Results of surgical treatment of ruptured abdominal aortic aneurysms]V Vukobratov, J Pfau, Z Horvat, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Vascular problems in kidney transplantation--initial experience]S Avramov, P Petrović, J Pfau, et al.
The Annals of Pharmacotherapy|January 7, 2017
Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid MalignanciesAmber C King, Tim J Peterson, Troy Z Horvat, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Recurrence after surgery of the varicose syndrome of the lower extremities]S Avramov, P Petrović, J Pfau, et al.
Journal of Clinical & Laboratory Immunology|July 1, 1991
Natural killer cell number and activity in remission phase of systemic connective tissue diseasesJ Markeljević, M Marusić, B Uzarević, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Postphlebitic syndrome, surgical treatment of superficial venous insufficiency and zinc "boots"]M Fabri, Z Horvat, P Petrović, et al.
The Journal of Rheumatology|December 1, 1994
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseasesJ Markeljević, D Batinić, B Uzarević, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Acta Chirurgica Iugoslavica|January 1, 1989
[Vascular procedures in oncology surgery]P Petrović, Z Horvat, M Fabri, et al.
The Annals of Pharmacotherapy|May 21, 2015
Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncologyMeagan S Barbee, Adebayo Ogunniyi, Troy Z Horvat, et al.
The Annals of Pharmacotherapy|June 5, 2015
Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic LeukemiaLarry W Buie, Joshua J Pecoraro, Troy Z Horvat, et al.
Medicinski Pregled|February 21, 1998
[Results of surgical treatment of ruptured abdominal aortic aneurysms]V Vukobratov, J Pfau, Z Horvat, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Vascular problems in kidney transplantation--initial experience]S Avramov, P Petrović, J Pfau, et al.
The Annals of Pharmacotherapy|January 7, 2017
Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid MalignanciesAmber C King, Tim J Peterson, Troy Z Horvat, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Recurrence after surgery of the varicose syndrome of the lower extremities]S Avramov, P Petrović, J Pfau, et al.
Journal of Clinical & Laboratory Immunology|July 1, 1991
Natural killer cell number and activity in remission phase of systemic connective tissue diseasesJ Markeljević, M Marusić, B Uzarević, et al.
Acta Chirurgica Iugoslavica|January 1, 1989
[Postphlebitic syndrome, surgical treatment of superficial venous insufficiency and zinc "boots"]M Fabri, Z Horvat, P Petrović, et al.
The Journal of Rheumatology|December 1, 1994
Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseasesJ Markeljević, D Batinić, B Uzarević, et al.
Pageof 5